A switch from conventional twice-daily tacrolimus to once-daily extended-release tacrolimus in stable kidney transplant recipients

Transplantation Proceedings

Volumn 44, Issue 1, 2012, Pages 121-123

  Hatakeyama, S ^a   Fujita, T ^a   Yoneyama, T ^a,a   Koie, T ^a   Hashimoto, Y ^b   Saitoh, H ^b   Funyu, T ^b   Narumi, S ^a   Ohyama, C ^a  

^a HIROSAKI UNIVERSITY   (Japan)

^b Oyokyo Kidney Research Institute   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; GLUCOSE; HEMOGLOBIN A1C; POTASSIUM; TACROLIMUS;

ADULT; CLINICAL ARTICLE; CONFERENCE PAPER; CREATININE BLOOD LEVEL; DRUG SAFETY; FEMALE; FOLLOW UP; GRAFT RECIPIENT; HUMAN; KIDNEY FUNCTION; KIDNEY GRAFT; KIDNEY TRANSPLANTATION; MALE; PATIENT SATISFACTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN URINE LEVEL; TREATMENT DURATION;

ADULT; BIOLOGICAL MARKERS; DELAYED-ACTION PREPARATIONS; DRUG ADMINISTRATION SCHEDULE; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; IMMUNOSUPPRESSIVE AGENTS; JAPAN; KIDNEY TRANSPLANTATION; MALE; MEDICATION ADHERENCE; MIDDLE AGED; PATIENT SATISFACTION; PROSPECTIVE STUDIES; QUESTIONNAIRES; TACROLIMUS; TREATMENT OUTCOME;

EID: 84858743257     PISSN: 00411345     EISSN: 18732623     Source Type: Journal    
DOI: 10.1016/j.transproceed.2011.11.022     Document Type: Conference Paper

References (8)

1. R. Alloway, S. Steinberg, K. Khalil Conversion of stable kidney transplant recipients from a twice daily Prograf-based regimen to a once daily modified release tacrolimus-based regimen Transplant Proc 37 2005 867
2. R. Alloway, S. Steinberg, K. Khalil Two years postconversion from a prograf-based regimen to a once-daily tacrolimus extended-release formulation in stable kidney transplant recipients Transplantation 83 2007 1648
3. A. Mecule, L. Poli, I. Nofroni Once daily tacrolimus formulation: monitoring of plasma levels, graft function, and cardiovascular risk factors Transplant Proc 42 2011 1317
4. E. Gallego-Valcarce, A. Ortega-Cerrato, F. Llamas-Fuentes Conversion to tacrolimus extended-release formulation: short-term clinical results Transplant Proc 41 2009 2326
5. M.R. First, W.E. Fitzsimmons Modified release tacrolimus Yonsei Med J 45 2004 1127
6. Y. Miura, S. Satoh, M. Saito Factors increasing quantitative interstitial fibrosis from 0 hr to 1 year in living kidney transplant patients receiving tacrolimus Transplantation 91 2011 78
7. K. Denhaerynck, F. Dobbels, I. Cleemput Prevalence, consequences, and determinants of nonadherence in adult renal transplant patients: a literature review Transpl Int 18 2005 1121
8. G. Schmid-Mohler, M.P. Thut, R.P. Wuthrich Non-adherence to immunosuppressive medication in renal transplant recipients within the scope of the Integrative Model of Behavioral Prediction: a cross-sectional study Clin Transplant 24 2010 213